Clinical Trial Update: Gemcitabine and Cisplatin for Gallbladder and Biliary Tract Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating gemcitabine and cisplatin for gallbladder cancer and biliary tract cancer has completed. The study was sponsored by the Dana-Farber C…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Gallbladder Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Gallbladder Cancer, Biliary Tract Cancer | Phase 2 | Status: COMPLETED